BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 18957849)

  • 1. Presenilin 1 polymorphism associated with Alzheimer's disease in apolipoprotein E4 carriers.
    Martínez-García A; Aldudo J; Recuero M; Sastre I; Vilella-Cuadrada E; Rosich-Estragó M; Frank A; Valdivieso F; Bullido MJ
    Dement Geriatr Cogn Disord; 2008; 26(5):440-4. PubMed ID: 18957849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association study and meta-analysis of Alzheimer's disease risk and presenilin-1 intronic polymorphism.
    Rodríguez-Manotas M; Amorín-Díaz M; Cañizares-Hernández F; Ruíz-Espejo F; Martínez-Vidal S; González-Sarmiento R; Martínez-Hernández P; Cabezas-Herrera J
    Brain Res; 2007 Sep; 1170():119-28. PubMed ID: 17719017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PSEN1 polymorphisms alter the rate of cognitive decline in sporadic Alzheimer's disease patients.
    Belbin O; Beaumont H; Warden D; Smith AD; Kalsheker N; Morgan K
    Neurobiol Aging; 2009 Dec; 30(12):1992-9. PubMed ID: 18403054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular genetics of Alzheimer's disease: an update.
    Brouwers N; Sleegers K; Van Broeckhoven C
    Ann Med; 2008; 40(8):562-83. PubMed ID: 18608129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic association of the presenilin-1 regulatory region with early-onset Alzheimer's disease in a population-based sample.
    van Duijn CM; Cruts M; Theuns J; Van Gassen G; Backhovens H; van den Broeck M; Wehnert A; Serneels S; Hofman A; Van Broeckhoven C
    Eur J Hum Genet; 1999; 7(7):801-6. PubMed ID: 10573013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphism of the regulatory region of the presenilin-2 gene in sporadic Alzheimer's disease: a case-control study.
    Quan W; Yasuda M; Hashimoto M; Yamamoto Y; Ishii K; Kazui H; Mori E; Kakigi T; Maeda K
    J Neurol Sci; 2006 Jan; 240(1-2):71-5. PubMed ID: 16233903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mutation screening by DHPLC of PSEN1 and APP genes reveals no significant variation associated with the sporadic late-onset form of Alzheimer's disease.
    Scacchi R; Gambina G; Moretto G; Corbo RM
    Neurosci Lett; 2007 May; 418(3):282-5. PubMed ID: 17412506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between presenilin 1 intronic polymorphism and late onset Alzheimer's disease in the North Chinese population.
    Jia L; Zhou C; Lv H; Wang W; Ye J; Zhang X; Zhou W; Xu J; Wang L; Jia J
    Brain Res; 2006 Oct; 1116(1):201-5. PubMed ID: 16938285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin converting enzyme insertion/deletion polymorphism in sporadic and familial Alzheimer's disease and longevity.
    Nacmias B; Bagnoli S; Tedde A; Cellini E; Bessi V; Guarnieri B; Ortensi L; Piacentini S; Bracco L; Sorbi S
    Arch Gerontol Geriatr; 2007; 45(2):201-6. PubMed ID: 17182125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of apolipoprotein E4 isoform in Alzheimer's disease in Poland.
    Bratosiewicz-Zapart J; Kłoszewska I; Sobów T; Liberski PP
    Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):221-2. PubMed ID: 9597090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic study of Sardinian patients with Alzheimer's disease.
    Piscopo P; Manfredi A; Malvezzi-Campeggi L; Crestini A; Spadoni O; Cherchi R; Deiana E; Piras MR; Confaloni A
    Neurosci Lett; 2006 May; 398(1-2):124-8. PubMed ID: 16423463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presenilin-1 polymorphism in Alzheimer's disease and vascular dementia.
    Matsushita S; Arai H; Muramatsu T; Makimoto K; Nakagawa T; Sasaki H; Higuchi S
    Exp Neurol; 1997 Aug; 146(2):567-9. PubMed ID: 9270069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that Abeta42 plasma levels in presenilin-1 mutation carriers do not allow for prediction of their clinical phenotype.
    De Jonghe C; Cras P; Vanderstichele H; Cruts M; Vanderhoeven I; Smouts I; Vanmechelen E; Martin JJ; Hendriks L; Van Broeckhoven C
    Neurobiol Dis; 1999 Aug; 6(4):280-7. PubMed ID: 10448055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein Eepsilon4 modifies Alzheimer's disease onset in an E280A PS1 kindred.
    Pastor P; Roe CM; Villegas A; Bedoya G; Chakraverty S; García G; Tirado V; Norton J; Ríos S; Martínez M; Kosik KS; Lopera F; Goate AM
    Ann Neurol; 2003 Aug; 54(2):163-9. PubMed ID: 12891668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic analysis of tumor necrosis factor-alpha (TNF-alpha) G-308A and Saitohin Q7R polymorphisms with Alzheimer's disease.
    Wang B; Zhou S; Yang Z; Xie YC; Wang J; Zhang P; Lv Z; Zheng C; Ma X
    J Neurol Sci; 2008 Jul; 270(1-2):148-51. PubMed ID: 18396294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CDC2 I-G-T haplotype associated with the APOE epsilon4 allele increases the risk of sporadic Alzheimer's disease in Sicily.
    Bosco P; Caraci F; Copani A; Spada RS; Sortino MA; Salluzzo R; Salemi M; Nicoletti F; Ferri R
    Neurosci Lett; 2007 Jun; 419(3):195-8. PubMed ID: 17498878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic interaction between tau and the apolipoprotein E receptor LRP1 Increases Alzheimer's disease risk.
    Vázquez-Higuera JL; Mateo I; Sánchez-Juan P; Rodríguez-Rodríguez E; Pozueta A; Infante J; Berciano J; Combarros O
    Dement Geriatr Cogn Disord; 2009; 28(2):116-20. PubMed ID: 19684401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The urokinase-type plasminogen activator polymorphism PLAU_1 is a risk factor for APOE-epsilon4 non-carriers in the Italian Alzheimer's disease population and does not affect the plasma Abeta(1-42) level.
    Pesaresi M; Batelli S; Prato F; Polito L; Lovati C; Scarpini E; Quadri P; Mariani C; Albani D; Forloni G
    Neurobiol Dis; 2007 Mar; 25(3):609-13. PubMed ID: 17174555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presenilin-1 gene intronic polymorphism and late-onset Alzheimer's disease.
    Dursun E; Gezen-Ak D; Eker E; Ertan T; Engin F; Hanagasi H; Gürvit H; Emre M; Yilmazer S
    J Geriatr Psychiatry Neurol; 2008 Dec; 21(4):268-73. PubMed ID: 19017784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The APOE-491 A/T promoter polymorphism effect on cognitive profile of Alzheimer's patients.
    Valenza A; Bizzarro A; Marra C; Lauria A; Guglielmi V; Rossi C; Tiziano FD; Brahe C; Masullo C
    Neurosci Lett; 2010 Mar; 472(3):199-203. PubMed ID: 20152880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.